Linova Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 15 Year, 8 Months
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 1.50 M
- Revenue Growth 2.01%
- Profit Growth 34.66%
- Ebitda 1.47%
- Net Worth 11.92%
- Total Assets 1.66%
About Linova Life Sciences
Linova Life Sciences Private Limited (LLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 June 2009 and has a history of 15 years and eight months. Its registered office is in Khorda, Odisha, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹1.50 M.
Sachikanta Behera, Rohit Samantaroy, and Rashmi Mangaraj serve as directors at the Company.
Company Details
-
Location
Khorda, Odisha, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51109OR2009PTC010881
-
Company No.
010881
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jun 2009
-
Date of AGM
30 Sep 2017
-
Date of Balance Sheet
31 Mar 2017
-
Listing Status
Unlisted
-
ROC Code
Roc Cuttack
Industry
Who are the key members and board of directors at Linova Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Mangaraj
|
Managing Director | 12-Jun-2009 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sachikanta Behera
|
Director | 01-Dec-2022 | Current |
|
Rohit Samantaroy
|
Additional Director | 14-Aug-2012 | Current |
Financial Performance of Linova Life Sciences.
Linova Life Sciences Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 2.01% increase. The company also saw a substantial improvement in profitability, with a 34.66% increase in profit. The company's net worth Soared by an impressive increase of 11.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Linova Life Sciences?
In 2017, Linova Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mautir Ai LimitedSachikanta Behera is a mutual person
-
Sallet It Soft Private Limited
Sachikanta Behera is a mutual person
Charges (Loans)
₹1.50 M
₹0
Charges Breakdown by Lending Institutions
- Andhra Bank : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 May 2013 | Andhra Bank | ₹1.50 M | Open |
How Many Employees Work at Linova Life Sciences?
Unlock and access historical data on people associated with Linova Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Linova Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Linova Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
